753 related articles for article (PubMed ID: 32385649)
1. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
Wang Y; Zhu GQ; Zhou CW; Li N; Yang C; Zeng MS
Eur Radiol; 2022 Aug; 32(8):5166-5178. PubMed ID: 35316365
[TBL] [Abstract][Full Text] [Related]
3. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
Zhang J; Dong W; Li Y; Fu J; Jia N
Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
[TBL] [Abstract][Full Text] [Related]
4. Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma.
Zhang J; Dong W; Liu W; Fu J; Liao T; Li Y; Huo L; Jia N
Abdom Radiol (NY); 2024 Mar; 49(3):710-721. PubMed ID: 38112787
[TBL] [Abstract][Full Text] [Related]
5. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.
Wang T; Yang X; Tang H; Kong J; Shen S; Qiu H; Wang W
Aging (Albany NY); 2020 Aug; 12(15):15334-15358. PubMed ID: 32788423
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
8. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma.
Granata V; Fusco R; Venanzio Setola S; Sandomenico F; Luisa Barretta M; Belli A; Palaia R; Tatangelo F; Grassi R; Izzo F; Petrillo A
Radiol Oncol; 2020 May; 54(2):149-158. PubMed ID: 32463393
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics.
Chen Y; Lu Q; Zhu Y; Huang B; Dong Y; Wang W
Ultrasound Med Biol; 2022 Jul; 48(7):1190-1201. PubMed ID: 35397928
[TBL] [Abstract][Full Text] [Related]
10. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
[TBL] [Abstract][Full Text] [Related]
11. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
12. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
Lee HS; Kim MJ; An C
Eur Radiol; 2019 May; 29(5):2408-2416. PubMed ID: 30552477
[TBL] [Abstract][Full Text] [Related]
13. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
Xiao Y; Zheng X; Zhou C; Huang P; Wu F; Yang C; Zeng M
Eur Radiol; 2023 Feb; 33(2):1412-1421. PubMed ID: 36112193
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.
Jeon SK; Joo I; Lee DH; Lee SM; Kang HJ; Lee KB; Lee JM
Eur Radiol; 2019 Jan; 29(1):373-382. PubMed ID: 29955948
[TBL] [Abstract][Full Text] [Related]
15. Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.
Zhou C; Lu X; Wang Y; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Oct; 32(10):6702-6711. PubMed ID: 35976399
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosis.
Yoon J; Hwang JA; Lee S; Lee JE; Ha SY; Park YN
Liver Int; 2021 Jul; 41(7):1641-1651. PubMed ID: 33503328
[TBL] [Abstract][Full Text] [Related]
17. Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.
Kim DH; Choi SH; Kim DW; Lee SS; Lim YS; Kim SY; Kim HJ; Kim JH; Byun JH
J Magn Reson Imaging; 2021 Jun; 53(6):1803-1812. PubMed ID: 33565208
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
Tang D; Nagano H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
J Gastrointest Surg; 2006; 10(7):987-98. PubMed ID: 16843869
[TBL] [Abstract][Full Text] [Related]
19. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
Chen J; Zhou J; Kuang S; Zhang Y; Xie S; He B; Deng Y; Yang H; Shan Q; Wu J; Sirlin CB; Wang J
AJR Am J Roentgenol; 2019 Oct; 213(4):821-830. PubMed ID: 31120791
[No Abstract] [Full Text] [Related]
20. LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.
Hwang JA; Lee S; Lee JE; Yoon J; Choi SY; Shin J
J Magn Reson Imaging; 2023 Mar; 57(3):930-938. PubMed ID: 35833798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
